Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$4.2M
Filings
45
Firms Hired
2
Active Period
2005–2011
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Safeguarding America's Pharmaceuticals Act of 2011
2011 · fourth_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 3026, Safeguarding America's Pharmaceuticals Act of 2011 and issues pertaining to pedigree; issues pertaining to drug safety.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3026
Safeguarding America's Pharmaceuticals Act of 2011
2011 · third_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 3026, Safeguarding America's Pharmaceuticals Act of 2011 and issues pertaining to pedigree; issues pertaining to drug safety.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3026
Health Care Cost Reduction Act of 2012
2011 · second_quarter · Firm: THE NICKLES GROUP, LLC
S. 17/H.R. 436, Medical Device Access and Innovation Protection Act. Issues related to the taxation of medical devices and pharmaceuticals. Issues related to the taxation of foreign-based multinational corporations, corporate tax reform, and the R&D tax credit.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 436
Repealing the Job-Killing Health Care Law Act
2011 · first_quarter · Firm: ALCON LABORATORIES, INC.
S. 17/H.R. 436, Medical Device Access and Innovation Protection Act. HR 2/S. 192, Repealing the Job-Killing Health Care Law Act. Issues related to the taxation of medical devices and pharmaceuticals. Issues related to the taxation of foreign-based multinational corporations, corporate tax reform, and the R&D tax credit.
Client expense: $540,000 · Firm income: —
Matched citations: HR 2
Health Care Cost Reduction Act of 2012
2011 · first_quarter · Firm: ALCON LABORATORIES, INC.
S. 17/H.R. 436, Medical Device Access and Innovation Protection Act. HR 2/S. 192, Repealing the Job-Killing Health Care Law Act. Issues related to the taxation of medical devices and pharmaceuticals. Issues related to the taxation of foreign-based multinational corporations, corporate tax reform, and the R&D tax credit.
Client expense: $540,000 · Firm income: —
Matched citations: H.R. 436
Repealing the Job-Killing Health Care Law Act
2011 · first_quarter · Firm: THE NICKLES GROUP, LLC
S. 17/H.R. 436, Medical Device Access and Innovation Protection Act. HR 2/S. 192, Repealing the Job-Killing Health Care Law Act. Issues related to the taxation of medical devices and pharmaceuticals. Issues related to the taxation of foreign-based multinational corporations, corporate tax reform, and the R&D tax credit.
Client expense: — · Firm income: $60,000
Matched citations: HR 2
Health Care Cost Reduction Act of 2012
2011 · first_quarter · Firm: THE NICKLES GROUP, LLC
S. 17/H.R. 436, Medical Device Access and Innovation Protection Act. HR 2/S. 192, Repealing the Job-Killing Health Care Law Act. Issues related to the taxation of medical devices and pharmaceuticals. Issues related to the taxation of foreign-based multinational corporations, corporate tax reform, and the R&D tax credit.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 436
To amend the Small Business Act to provide for an increase in the amount of awards under the first and second phases of the Small Business Innovation Research program.
2010 · fourth_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 4213, The Tax Extenders Act, H.R. 5297, the Small Business Jobs & Credit Act, and H.R. 4853, Tax Relief Unemployment Insurance Reauthorization and Job Creation Act, as they relate to the research and development tax credit. H.R. 5328, the International Tax Competitiveness Act, as it relates to the taxation of foreign-based multinational corporations.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4213
Veterans Self-Employment Act of 2007
2010 · fourth_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 4213, The Tax Extenders Act, H.R. 5297, the Small Business Jobs & Credit Act, and H.R. 4853, Tax Relief Unemployment Insurance Reauthorization and Job Creation Act, as they relate to the research and development tax credit. H.R. 5328, the International Tax Competitiveness Act, as it relates to the taxation of foreign-based multinational corporations.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4853
To suspend temporarily the duty on certain tirebuilding machines used in the manufacture of extra-wide pneumatic truck and automobile tires, and parts and accessories thereof.
2010 · fourth_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 4213, The Tax Extenders Act, H.R. 5297, the Small Business Jobs & Credit Act, and H.R. 4853, Tax Relief Unemployment Insurance Reauthorization and Job Creation Act, as they relate to the research and development tax credit. H.R. 5328, the International Tax Competitiveness Act, as it relates to the taxation of foreign-based multinational corporations.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5297
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · fourth_quarter · Firm: THE NICKLES GROUP, LLC
S. 525, S. 1232 / H.R. 1298, The Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act and H.R. 6543, The Drug Safety Enhancement Act as they relate to drug safety and pedigree issues.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1298
Medicare and Medicaid Extenders Act of 2010
2010 · fourth_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 5712, The Physician Payment & Therapy Relief Act & H.R. 4994, The Medicare & Medicaid Extenders Act of 2010 as they relate to Medicare physician payments.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4994
International Tax Competitiveness Act of 2010
2010 · fourth_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 4213, The Tax Extenders Act, H.R. 5297, the Small Business Jobs & Credit Act, and H.R. 4853, Tax Relief Unemployment Insurance Reauthorization and Job Creation Act, as they relate to the research and development tax credit. H.R. 5328, the International Tax Competitiveness Act, as it relates to the taxation of foreign-based multinational corporations.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5328
Physician Payment and Therapy Relief Act of 2010
2010 · fourth_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 5712, The Physician Payment & Therapy Relief Act & H.R. 4994, The Medicare & Medicaid Extenders Act of 2010 as they relate to Medicare physician payments.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5712
Drug Safety Enhancement Act of 2011
2010 · fourth_quarter · Firm: THE NICKLES GROUP, LLC
S. 525, S. 1232 / H.R. 1298, The Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act and H.R. 6543, The Drug Safety Enhancement Act as they relate to drug safety and pedigree issues.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6543
Food and Drug Administration Globalization Act of 2009
2010 · fourth_quarter · Firm: THE NICKLES GROUP, LLC
S. 525, S. 1232 / H.R. 1298, The Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act and H.R. 6543, The Drug Safety Enhancement Act as they relate to drug safety and pedigree issues.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 759
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · fourth_quarter · Firm: THE NICKLES GROUP, LLC
S. 525, S. 1232 / H.R. 1298, The Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act and H.R. 6543, The Drug Safety Enhancement Act as they relate to drug safety and pedigree issues.
Client expense: — · Firm income: $60,000
Matched citations: S. 1232
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · fourth_quarter · Firm: THE NICKLES GROUP, LLC
S. 525, S. 1232 / H.R. 1298, The Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act and H.R. 6543, The Drug Safety Enhancement Act as they relate to drug safety and pedigree issues.
Client expense: — · Firm income: $60,000
Matched citations: S. 525
To amend the Small Business Act to provide for an increase in the amount of awards under the first and second phases of the Small Business Innovation Research program.
2010 · third_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 4213, The Tax Extenders Act and H.R. 5297, the Small Business Jobs & Credit Act, as they relate to the research and development tax credit. H.R. 5328, the International Tax Competitiveness Act, as it relates to the taxation of foreign-based multinational corporations.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4213
To suspend temporarily the duty on certain tirebuilding machines used in the manufacture of extra-wide pneumatic truck and automobile tires, and parts and accessories thereof.
2010 · third_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 4213, The Tax Extenders Act and H.R. 5297, the Small Business Jobs & Credit Act, as they relate to the research and development tax credit. H.R. 5328, the International Tax Competitiveness Act, as it relates to the taxation of foreign-based multinational corporations.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5297
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · third_quarter · Firm: THE NICKLES GROUP, LLC
S. 525, S. 1232 / H.R. 1298, The Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree and drug safety legislation.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1298
International Tax Competitiveness Act of 2010
2010 · third_quarter · Firm: THE NICKLES GROUP, LLC
H.R. 4213, The Tax Extenders Act and H.R. 5297, the Small Business Jobs & Credit Act, as they relate to the research and development tax credit. H.R. 5328, the International Tax Competitiveness Act, as it relates to the taxation of foreign-based multinational corporations.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5328
Food and Drug Administration Globalization Act of 2009
2010 · third_quarter · Firm: THE NICKLES GROUP, LLC
S. 525, S. 1232 / H.R. 1298, The Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree and drug safety legislation.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 759
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · third_quarter · Firm: THE NICKLES GROUP, LLC
S. 525, S. 1232 / H.R. 1298, The Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree and drug safety legislation.
Client expense: — · Firm income: $60,000
Matched citations: S. 1232
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · third_quarter · Firm: THE NICKLES GROUP, LLC
S. 525, S. 1232 / H.R. 1298, The Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree and drug safety legislation.
Client expense: — · Firm income: $60,000
Matched citations: S. 525
Source: Senate LDA